Short-term benefit from oral vancomycin treatment of regressive-onset autism

Journal of Child Neurology

Volumn 15, Issue 7, 2000, Pages 429-435

  Sandler, Richard H ^a   Finegold, Sydney M ^b   Bolte, Ellen R ^a   Buchanan, Cathleen P ^a   Maxwell, Anne P ^a   Väisänen, Marja Liisa ^b   Nelson, Michael N ^a   Wexler, Hannah M ^b  

^a Rush Children's Hospital and Rush University Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; AUTISM; BACTERIAL COLONIZATION; CHILD; CHILD DEVELOPMENT; CHRONIC DIARRHEA; CLINICAL ARTICLE; DETERIORATION; DRUG ABSORPTION; FEMALE; HUMAN; INTESTINE FLORA; MALE; NEUROTOXICITY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADMINISTRATION, ORAL; AUTISTIC DISORDER; BACTERIA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; NEUROPSYCHOLOGICAL TESTS; REGRESSION (PSYCHOLOGY); VANCOMYCIN;

EID: 0033929819     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500701     Document Type: Article

References (43)

1. Kanner L: Autistic disturbances of affective contact. Nerv Child 1943;2:217-250.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, American Psychiatric Association, 1994, pp 57-58.
3. Rutter M: Autistic children: Infancy to adulthood. Semin Psychiatry 1970;2:435-450.
4. Bryson SE: Brief report: Epidemiology of autism. J Autism Dev Disord 1996;26:165-167.
5. Gillberg C, Coleman M: The Biology of the Autistic Syndromes, 2nd ed. New York, Cambridge University Press, 1992, pp 203-217.
6. Rapin I: Autism. N Engl J Med 1997;337:97-104.
7. Bolte ER: Autism and Clostridium tetani. Med Hypotheses 1998; 51:133-144.
8. Montecucco C, Schiavo G: Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 1994;13:1-8.
9. Kelly C, LaMont J: Clostridium difficile infection. Annu Rev Med 1998;29:375-390.
10. Hospital Infection Control Practice Advisory Committee: Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-113.
11. Tuchman RF, Rapin I: Regression in pervasive developmental disorders: Seizures and epileptiform electroencephalogram correlates. Pediatrics 1997;99:560-566.
12. Alpern G, Boll T, Shearer M: Developmental Profile II. Los Angeles, Western Psychological Services, 1995.
13. Schopler E, Reichler R, Renner B: The Autism Rating Scale Manual. Los Angeles, Western Psychological Services, 1995.
14. Littman G, Walker B, Schneider B: Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 1985;38:16-23.
15. Summanen P, Baron EJ, Citron DM, et al: Wadsworth Anaerobic Bacteriology Manual, 5th ed. Belmont, CA, Star Publishing, 1993.
16. Finegold S, Sutter V, Mathisen G: Normal indigenous intestinal flora, in Hentges DJ (ed): Human Intestinal Flora in Health and Disease. New York, Academic Press, 1983, pp 3-31.
17. Bristol MM, Cohen DJ, Costello EJ, et al: State of the science in autism: Report to the National Institutes of Health. J Autism Dev Disord 1996;26:121-154.
18. D'Eufemia P, Celli M, Finocchiaro R, et al: Abnormal intestinal permeability in children with autism. Acta Paediatr 1996;85:1076-1079.
19. Wakefield A, Murch S, Anthony A, et al: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-641.
20. Pickett J, Berg B, Chaplin E, Brunstetter-Shafer M: Syndrome of botulism in infancy: Clinical and electrophysiologic study. N Engl J Med 1976;295:770-772.
21. Wilcke B, Midura T, Arnon S: Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis 1980;141:419-423.
22. Cherington M: Clinical spectrum of botulism. Muscle Nerve 1998; 21:701-710.
23. Burr DH, Sugiyama H: Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice. Infect Immun 1982;36: 103-106.
24. Shapiro RL, Hatheway C, Swerdlow DL: Botulism in the United States: A clinical and epidemiologic review. Ann Intern Med 1998;129:221-228.
25. van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC: Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971;69:405-411.
26. Barza M, Guiliano M, Jacobus NV, Gorbach SL: Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans. Antimicrob Agents Chemother 1987;31:723-727.
27. Hentges DJ, Stein AJ, Casey SW, Qui JU: Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: Influence of antibiotics on colonization resistance. Infect Immun 1985;47:118-122.
28. Bohnhoff M, Miller CP: Enhanced susceptibility to Salmonella infection in streptomycin treated mice. J Infect Dis 1962;111: 117-127.
29. Freter R: Experimental enteric Shigella and Vibrio infections in mice and guinea pigs. J Exp Med 1956;104:411-418.
30. Stolberg L, Rolfe R, Gitlin N, et al: D-Lactic acidosis due to abnormal gut flora: Diagnosis and treatment of two cases. N Engl J Med 1982;306:1344-1348.
31. Traube M, Bock J, Boyer J: D-Lactic acidosis after jejunoileal bypass: Identification of organic anions by nuclear magnetic resonance spectroscopy. Ann Intern Med 1983;98:171-173.
32. Eaves L, Ho H: Brief report: Stability and changes in cognitive and behavioral characteristics of autism through childhood. J Autism Dev Disord 1996;26:557-569.
33. Buggy BP, Fekety R, Silva Jr J: Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987;9:155-159.
34. Singh VK, Warren R, Averett R, Ghaziuddin M: Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 1997;17:88-90.
35. Singh VK, Warren RP, Odell JD, et al: Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993;7:97-103.
36. Tiwana H, Wilson C, Alvarez A, et al: Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 1999;67:2769-2775.
37. Giuliano M, Barza M, Jacobus V, Gorbach SL: Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 1987;31:202-206.
38. Ramare F, Nicoli J, Dabard J, et al: Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl Environ Microbiol 1993; 59:2876-2883.
39. Hentges DJ: The protective function of the indigenous intestinal flora. Pediatr Infect Dis 1986;5(Suppl):S17-S20.
40. Benno Y, Sawada K, Mitsuoka T: The intestinal microflora of infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984;28:975-986.
41. Mata L, Mejicanos M, Jimenez, F: Studies on the indigenous gastrointestinal flora of Guatemalan children. Am J Clin Nutr 1972; 25:1380-1390.
42. Ellis-Pegler R, Crabtree C, Lambert H: The fecal flora of children in the United Kingdom. J Hyg (Lond) 1975;75:135-142.
43. Conway P: Microbial ecology of the human large intestine, in Gibson G, Macfarlane G (eds): Human Colonic Bacteria - Role in Nutrition, Physiology, and Pathology. Boca Raton, FL, CRC Press, 1995, pp 1-24.